Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (261-270 of 409) with videos related to

Pageof 41
Sort By:
Iscience|November 24, 2018
Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune InfiltrationZeya Wang, Shaolong Cao, Jeffrey S Morris, et al.
Nature Medicine|February 21, 2024
Author Correction: An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κBJunxia Min, Alexander Zaslavsky, Giuseppe Fedele, et al.
Molecular Cancer Therapeutics|October 22, 2017
AKT1<sup>low</sup> Quiescent Cancer Cells Promote Solid Tumor GrowthCleidson P Alves, Ipsita Dey-Guha, Sheheryar Kabraji, et al.
Clinical Genitourinary Cancer|December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancerKevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
Cancer Discovery|December 16, 2016
Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast CancersSarah Naomi Olsen, Ania Wronski, Zafira Castaño, et al.
Nature Medicine|February 16, 2010
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaBJunxia Min, Alexander Zaslavsky, Giuseppe Fedele, et al.
The American Journal of Clinical Nutrition|January 29, 2016
Dietary lycopene intake and risk of prostate cancer defined by ERG protein expressionRebecca E Graff, Andreas Pettersson, Rosina T Lis, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2017
Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicingTeng Fei, Yiwen Chen, Tengfei Xiao, et al.
American Journal of Epidemiology|April 30, 2025
Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancerZhike Lin, Konrad H Stopsack, Michelangelo Fiorentino, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2014
Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancerSun Yoo, Andreas Pettersson, Kristina M Jordahl, et al.
Pageof 41

Showing results (261-270 of 409) with videos related to

Sort By:
Pageof 41
Iscience|November 24, 2018
Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune InfiltrationZeya Wang, Shaolong Cao, Jeffrey S Morris, et al.
Nature Medicine|February 21, 2024
Author Correction: An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κBJunxia Min, Alexander Zaslavsky, Giuseppe Fedele, et al.
Molecular Cancer Therapeutics|October 22, 2017
AKT1<sup>low</sup> Quiescent Cancer Cells Promote Solid Tumor GrowthCleidson P Alves, Ipsita Dey-Guha, Sheheryar Kabraji, et al.
Clinical Genitourinary Cancer|December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancerKevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
Cancer Discovery|December 16, 2016
Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast CancersSarah Naomi Olsen, Ania Wronski, Zafira Castaño, et al.
Nature Medicine|February 16, 2010
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaBJunxia Min, Alexander Zaslavsky, Giuseppe Fedele, et al.
The American Journal of Clinical Nutrition|January 29, 2016
Dietary lycopene intake and risk of prostate cancer defined by ERG protein expressionRebecca E Graff, Andreas Pettersson, Rosina T Lis, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2017
Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicingTeng Fei, Yiwen Chen, Tengfei Xiao, et al.
American Journal of Epidemiology|April 30, 2025
Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancerZhike Lin, Konrad H Stopsack, Michelangelo Fiorentino, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2014
Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancerSun Yoo, Andreas Pettersson, Kristina M Jordahl, et al.
Pageof 41